Specifically, silencing SPCA2 in breast cancer cell lines reduced resting Ca2+, cell proliferation, anchorage-dependent growth, and breast tumour growth in mouse xenograft models, whereas over-expression of SPCA2 had opposite effects [227]. The gene discussed is ATP2C2; the disease is breast carcinoma.